Glenmark Life Science Shareholding Pattern

NSE: ALIVUS|BSE: 543322|Pharmaceuticals
₹1,025.20+₹19.70 (1.96%)

As on 30 Apr, 2026 | 15:29 IST

Shareholding Pattern

Promoters (74.87%)

Mutual Funds (5.63%)

Retail and other (12.56%)

Foreign institutions-FII (5.29%)

Other domestic institutions (1.64%)

Promoters

Summary Data

Category
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Promoters
74.87%
74.91%
74.91%
74.94%
Foreign institutions-FII
5.29%
5.09%
6.84%
6.42%
Other domestic institutions
1.64%
1.68%
1.60%
1.56%
Retail and other
12.56%
12.88%
12.78%
13.03%
Mutual Funds
5.63%
5.44%
3.87%
4.06%

FAQs

What is the promoter shareholding of Glenmark Life Science?

Plus

The promoters of Glenmark Life Science currently hold 74.87% of the company’s total shares.

What is the FII and DII shareholding of Glenmark Life Science?

Plus

Foreign Institutional Investors (FIIs) own 5.29%. Domestic Institutional Investors (DIIs) hold 1.64% of Glenmark Life Science.

What is the retail shareholding of Glenmark Life Science?

Plus

The retail shareholding of Glenmark Life Science is 12.56%

How often is the shareholding pattern of Glenmark Life Science updated?

Plus

The shareholding pattern of Glenmark Life Science is updated quarterly as per SEBI regulations.

home
/
stocks
/
Glenmark Life Science Shareholding Pattern